The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.

At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other ...

Alignment Healthcare's high star ratings enable it to capture rival companies' members, Chief Financial Officer Thomas ...

Medicare Advantage (MA) insurers Alignment Healthcare and Clover Health both reported increased membership growth ahead of ...

It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...

The current head of the Center for Medicare has advice for her successor: "Engaging everyone in the ecosystem" is the ...

After several years in the doldrums, pharmaceutical companies and biotechs expect an uptick in dealmaking in 2025, with some ...

Highlights from the third day included information about Quanterix's new SIMOA One platform, expected to launch at the end of ...

Biotech dealmaking is back — but smaller and more intimate. Deals disclosed in the early days of the new year indicate that ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.